The note states a buy call on MAHA BANK in the 83-84.5 range (CMP 83.79) with add-on-dip at 81, stop loss 79.5 and target 90 over a horizon of up to 10 days, citing a daily-chart breakout, a volume jump on intraday charts, a bullish RSI setup on the hourly chart and a higher-top higher-bottom structure.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
2548 notes · all time
The report projects ABREL's Q2FY27 presales to fall 83% YoY and EBITDA to remain negative at -29% margin.
Read this note →The report expects Lodha's Q2FY27 revenue to grow 38% YoY and presales to rise 12% YoY, citing an impressive launch pipeline.
Read this note →The report names Mahindra Lifespaces a top pick and expects Q2FY27 presales growth of 21% YoY.
Read this note →The report projects Godrej Properties' Q2FY27 presales to decline 12% YoY while revenue grows 13% YoY.
Read this note →The report highlights Phoenix Mills' rental-heavy portfolio providing stable, escalating rental income and expects 25% YoY EBITDA growth in Q2FY27.
Read this note →The report cites Prestige among southern developers showing strong branded-end demand traction and expects new launch records in Q3FY27.
Read this note →The report projects Kolte-Patil's Q2FY27 revenue to rise 165% YoY but EBITDA margin to remain negative at -5%.
Read this note →The report expects Brigade's Q2FY27 presales to fall 9% YoY but highlights its rental-heavy portfolio as a cash-flow cushion.
Read this note →The report lists Sobha as a top pick, expecting Q2FY27 PAT growth of 342% YoY driven by margin recovery.
Read this note →The report names Oberoi Realty a top pick, citing strong NCR/branded demand, 100% launch sellout, and projects Q2FY27 presales to surge 612% YoY.
Read this note →The report expects DLF's Q2FY27 revenue to decline 18% YoY and PAT to rise 24% YoY, with presales estimated to fall 71% YoY due to a high base.
Read this note →The report upgrades HOMEFIRST from REDUCE to ADD with a revised RI-based target price of INR 1,250, citing improving AUM growth visibility of ~25% CAGR over FY27-FY29E, steady profitability, and favorable risk-reward after valuation de-rating from 4.0x to 2.3x 1-yr forward P/BV.
Read this note →The note states a short-term 'Buy' on Sudarshan Chemical with a buying range of 1262-1275, add-on-dip at 1225, stop loss at 1199 and target of 1340 within up to 10 days, citing a bullish reversal from the 50 DEMA, a volume jump on intraday charts, a bullish RSI setup on the hourly chart and a higher-top higher-bottom hourly structure.
Read this note →The report maintains a BUY rating and raises the target price from Rs 1,470 to Rs 1,650, along with upward revisions to EPS estimates of 2.2% to 12.2% across FY27-29E.
Read this note →The report maintains a REDUCE rating but trims the target price slightly from Rs 3,280 to Rs 3,270, along with downward revisions to EPS estimates of about 4.5-4.9%.
Read this note →The report maintains a REDUCE rating with an unchanged DCF-based target price of Rs 12,660, noting mobile segment volume weakness amid handset market softness and elevated memory prices but healthy topline growth from improved realizations.
Read this note →The report maintains a REDUCE rating with an unchanged DCF-based target price of Rs 8,060 and unchanged EPS estimates, while noting expected Q2FY27 revenue growth of 31.3% YoY but a loss at the APAT level.
Read this note →The report maintains an ADD rating but trims the target price from Rs 1,375 to Rs 1,365 along with minor downward revisions to EPS estimates, using an SOTP valuation approach.
Read this note →The report upgrades the rating from ADD to BUY while keeping the target price unchanged at Rs 400 and EPS estimates unchanged.
Read this note →The report maintains a REDUCE rating with an unchanged target price of Rs 580 and unchanged EPS estimates.
Read this note →The report maintains a BUY rating but cuts the target price from Rs 925 to Rs 790, lowering the target P/E multiple from 28x to 25x and trimming EPS estimates to reflect near-term margin pressures and potential impact of price hikes on consumer affordability.
Read this note →The report maintains a BUY rating with an unchanged target price of Rs 225 and unchanged EPS estimates.
Read this note →The report maintains a REDUCE rating with an unchanged target price of Rs 1,530 and unchanged EPS estimates.
Read this note →The report maintains an ADD rating with an unchanged target price of Rs 1,245 and broadly unchanged EPS estimates, expecting strong Q2FY27 revenue growth of 27.6% YoY.
Read this note →